Now the the three biggest inhaler manufacturers are capping their price at $35. AstraZeneca and Boehinger on June I and Glazoklinesmith on Jan 1 25. I noticed that the cap of $35 for each inhaler applies only to those in commercial insurance or no insurance at all. I guess I’m stuck with using GoodRx since my Part D Medicare coverage is so poor for these. The new provision from the drug companies ignores those on Medicare. Very disappointing